EP
GPCR icon

Eversept Partners’s Structure Therapeutics GPCR Stock Holding History

Eversept Partners’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
196,302
+58,266
+42% +$2.58M 0.55% 47
2026
Q1 		$6.65M Buy
138,036
+10,475
+8% +$717K 0.35% 54
2025
Q4 		$8.87M Sell
127,561
-38,830
-23% -$1.59M 0.45% 56
2025
Q3 		$4.66M Buy
166,391
+67,053
+67% +$1.34M 0.32% 50
2025
Q2 		$2.06M Buy
+99,338
New +$2.18M 0.19% 53

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Eversept Partners's GPCR Position: Q2 2026 in Review

Eversept Partners increased its Structure Therapeutics (GPCR) stake by 42% in Q2 2026, buying an estimated $2.58M and bringing the position to 196,302 shares worth $10.5M. The position accounts for 0.55% of the portfolio, ranked #47.

Eversept Partners first reported a position in GPCR in Q2 2025 and has held it in 5 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Eversept Partners held 196,302 shares of Structure Therapeutics worth $10.5M as of Q2 2026.
  • Eversept Partners bought 58,266 Structure Therapeutics shares in Q2 2026, an estimated $2.58M.
  • Structure Therapeutics made up 0.55% of Eversept Partners's portfolio in Q2 2026, its #47 holding.
  • Eversept Partners first reported a position in Structure Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.